Latest Posts



Mar 24

Partex NV announces collaboration with Althea DRF Lifesciences to provide comprehensive end-to-end services to accelerate drug discovery and development

Frankfurt, Germany; 28 March 2024 – Partex Group, a pioneer in AI-driven drug discovery, announces a collaboration with Althea DRF...
Read More


Mar 24

Innovative AI technology in oncology: Partex Group presents results from a pilot project

During the German Cancer Congress 2024 in Berlin, the companies Innoplexus AG /Amrit AG, companies of Partex N.V., presented the...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More


With the technological expertise in the areas of artificial intelligence and blockchain as well as its proficiency in Lifesciences, Innoplexus builds the fundament of Partex. 

Partex is redefining healthcare to become a lean digital pharma.

You will be rerouted to Partex, the legal entity handling the financial investments for the entire group.